Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Jagran Prakashan Q3 FY24 earnings call: Revenue & Margins | Arthneeti
Q3 FY24
510.96 Cr, up 5% YoY from Rs. Key concall takeaways from Jagran Prakashan Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.
24 Sept 2026
Jagran Prakashan Q4 FY24 earnings call: Revenue & Margins | Arthneeti
Q4 FY24
510 crore, up 11% YoY from Rs. Key concall takeaways from Jagran Prakashan Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.
24 Sept 2026
Jagran Prakashan Q1 FY25 earnings call: Revenue & Margins | Arthneeti
Q1 FY25
444.12 Cr, down 2% YoY from Rs. Key concall takeaways from Jagran Prakashan Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.
24 Sept 2026
Rajesh Power Services Q4 FY25: Revenue ₹1,107.44 Cr, EBITDA margin 12.08% | Arthneeti
Q4 FY25
Revenue from operations for FY25 was ₹1,107.44 crore, a 289% year-on-year (YoY) growth from ₹284.97 crore in FY24. Key concall takeaways from Rajesh Power…
24 Sept 2026
Expleo Solutions Q3 FY24 earnings call: Revenue & Margins | Arthneeti
Q3 FY24
Operating Revenue for Q3 FY24: Rs 2,502 million, up 4.2% YoY (vs Rs 2,402 million in Q3 FY23) (Page 6) . Key concall takeaways from Expleo Solutions Ltd's Q3…
24 Sept 2026
Expleo Solutions Q1 FY25 earnings call: Revenue & Margins | Arthneeti
Q1 FY25
Operating Revenue: Rs 2,522 million (up 12.0% YoY from Rs 2,251 million in Q1 FY24) [Page 6] . Key concall takeaways from Expleo Solutions Ltd's Q1 FY25…
24 Sept 2026
Expleo Solutions Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Operating Revenue for Q3 FY25: Rs 2,576 million, up 2.9% YoY (Page 6) . Key concall takeaways from Expleo Solutions Ltd's Q3 FY25 earnings call — and how it…
24 Sept 2026
Expleo Solutions Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Operating Revenue for Q1 FY26: Rs 2,596.5 million, up 3.0% YoY from Rs 2,521.7 million in Q1 FY25 (Page 10). Key concall takeaways from Expleo Solutions Ltd's…
24 Sept 2026
Expleo Solutions Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
Q3 FY26 Operating Revenue: Rs 2,794 million, up 8.5% Year-on-Year (YoY) from Rs 2,576 million in Q3 FY25 (Page 6). Key concall takeaways from Expleo Solutions…
24 Sept 2026
Expleo Solutions Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Operating Revenue for Q1 FY27: Rs 2,916 million, up 12.3% YoY (vs Rs 2,596 million in Q1 FY26) [Pages 5, 6, 10] . Key concall takeaways from Expleo Solutions…
24 Sept 2026
Walchandnagar Industries Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Nuclear power equipment opportunity: Qualifies for ~Rs 700 to Rs 1000 crores worth of equipment per nuclear power plant. Key concall takeaways from…
24 Sept 2026
Walchandnagar Industries Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Business revenue breakup for FY24: DNA (40.3%), OEM (26.5%), Foundry (7.9%), Process Equipment (25.2%) totaling 302 Cr in DNA segment. Key concall takeaways…
24 Sept 2026
Walchandnagar Industries Q2 FY25 earnings call: Revenue & Margins | Arthneeti
Q2 FY25
WIL’s qualification for equipment worth approximately ₹700 crores per Bharat Small Reactor (BSR) plant. Key concall takeaways from Walchandnagar Industries…
24 Sept 2026
Manaksia Coated Metals & Industries Q4 FY24: Revenue ₹182.55 Cr, PAT ₹5.34 Cr | Arthneeti
Q4 FY24
Q4 FY24 Standalone Revenue: ₹182.55 Cr vs. Key concall takeaways from Manaksia Coated Metals & Industries Ltd's Q4 FY24 earnings call — and how it ranks…
24 Sept 2026
Fermenta Biotech Q4 FY24 earnings call: Revenue & Margins | Arthneeti
Q4 FY24
Q4-FY24 Consolidated Operational Revenue: INR 973 Mn, down 7.5% YoY (Page 11) . Key concall takeaways from Fermenta Biotech Ltd's Q4 FY24 earnings call — and…
24 Sept 2026
Fermenta Biotech Q1 FY25 earnings call: Revenue & Margins | Arthneeti
Q1 FY25
Q1-FY25 consolidated operational revenue: INR 781 million, down 5.3% YoY (Q1-FY24: INR 824 million). Key concall takeaways from Fermenta Biotech Ltd's Q1 FY25…
24 Sept 2026
Fermenta Biotech Q4 FY25: Revenue ₹143.7 Cr, PAT ₹33.3 Cr | Arthneeti
Q4 FY25
Q4 FY25 Revenue: ₹143.7 crore . Key concall takeaways from Fermenta Biotech Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
24 Sept 2026
Fermenta Biotech Q2 FY25 earnings call: Revenue & Margins | Arthneeti
Q2 FY25
Standalone: INR 895 Mn, a 74.5% YoY increase (from INR 513 Mn in Q2-FY24) (Page 9) . Key concall takeaways from Fermenta Biotech Ltd's Q2 FY25 earnings call…
24 Sept 2026
Fermenta Biotech Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
Q3-FY25 consolidated operational revenue: INR 1,565 Mn, up 58.1% YoY (Page 12) . Key concall takeaways from Fermenta Biotech Ltd's Q3 FY25 earnings call — and…
24 Sept 2026
Fermenta Biotech Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Q1FY26 Revenue from operations: INR 136 crore, up 79% YoY (Page 8) . Key concall takeaways from Fermenta Biotech Ltd's Q1 FY26 earnings call — and how it ranks…
24 Sept 2026